How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Specimen Collection Kit Market
- By Kit Type: Blood Collection Kits, Urine Collection Kits, Saliva Collection Kits, Stool Collection Kits, Swab Collection Kits
- By End User: Hospitals, Diagnostic Laboratories, Home Healthcare Settings, Research Laboratories, Blood Banks
- By Sample Type: Whole Blood, Serum, Plasma, Urine, Saliva, Stool
- By Packaging Type: Single-use Kits, Multi-use Kits, Sterile Kits, Non-sterile Kits
- By Application: Infectious Disease Testing, Genetic Testing, Oncology Testing, Drug Testing, Prenatal Testing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Blood Collection Kits leads By Kit Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.185 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.193 →
Full report · locked preview
Everything inside the Specimen Collection Kit Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Kit Type 5
End User 5
Sample Type 6
Packaging Type 4
Application 5
Companies profiled
Thermo Fisher Scientific
Becton Dickinson (BD)
Greiner Bio-One International GmbH
Sarstedt AG & Co.
Copan Diagnostics Inc.
Fisher Healthcare
Nipro Corporation
VWR International (part of Avantor)
Qiagen N.V.
Hologic Inc.
Mawi DNA Technologies
Puritan Medical Products
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Becton Dickinson (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sarstedt AG & Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Copan Diagnostics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fisher Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →VWR International (part of Avantor)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Qiagen N.V.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hologic Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Mawi DNA Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Puritan Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →MP Biomedicals
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Eppendorf AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Kangjian Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,443M by 2033 · 7.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Blood Collection Kits36.1
- Urine Collection Kits16.5
- Saliva Collection Kits12.5
- Stool Collection Kits15.1
- Swab Collection Kits19.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$448.7M → $765.0M · 6.9%
Europe$312.8M → $511.1M · 6.3%
Asia Pacific$285.6M → $502.9M · 7.3%
Latin America$176.8M → $316.4M · 7.5%
Middle East and Africa$136.0M → $254.6M · 8.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.562026
7.552027
7.572028
7.592029
7.602030
7.602031
7.612032
7.642033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific11.8
- Becton Dickinson (BD)25.9
- Greiner Bio-One International GmbH6.0
- Sarstedt AG & Co.9.4
- Copan Diagnostics Inc.5.8
- Fisher Healthcare13.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Kit Type26.2%
End User13.6%
Sample Type17.2%
Packaging Type21.1%
Application21.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.6
- Europe21.8
- Asia Pacific21.4
- Latin America13.5
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 88 | 88 | 95 | 84 | 98 | 98 | 92 |
| Becton Dickinson (BD) | 78 | 85 | 83 | 86 | 71 | 91 | 82 |
| Greiner Bio-One International GmbH | 81 | 77 | 77 | 80 | 69 | 77 | 77 |
| Sarstedt AG & Co. | 76 | 57 | 58 | 61 | 61 | 68 | 64 |
| Copan Diagnostics Inc. | 62 | 56 | 64 | 73 | 53 | 69 | 63 |
| Fisher Healthcare | 53 | 52 | 57 | 66 | 60 | 59 | 58 |
| Nipro Corporation | 61 | 43 | 54 | 62 | 45 | 42 | 51 |
| VWR International (part of Avantor) | 58 | 53 | 48 | 54 | 45 | 37 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Becton Dickinson (BD)
- Greiner Bio-One International GmbH
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Becton Dickinson (BD) | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Greiner Bio-One International GmbH | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Sarstedt AG & Co. | ◐ | − | − | − | ◐ | ✓ |
| Copan Diagnostics Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Fisher Healthcare | − | − | − | ◐ | ◐ | − |
| Nipro Corporation | ◐ | − | − | ◐ | − | ◐ |
| VWR International (part of Avantor) | ◐ | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific92
2Becton Dickinson (BD)82
3Greiner Bio-One International GmbH77
4Sarstedt AG & Co.64
5Copan Diagnostics Inc.63
6Fisher Healthcare58
7Nipro Corporation51
8VWR International (part of Avantor)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificBecton Dickinson (BD)
Challenger1
Strong scale, closing on the leaders.
Greiner Bio-One International GmbH
Contender3
Focused players with pockets of strength.
Sarstedt AG & Co.Copan Diagnostics Inc.Fisher Healthcare
Niche2
Specialists in a single segment or region.
Nipro CorporationVWR International (part of Avantor)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Kit Type in North America, then scale across Specimen Collection Kit Market — a $308M beachhead inside a $5.40B market.
Beachhead (SOM)$308Mobtainable near-term
Serviceable (SAM)$1.91Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Blood Collection Kits
Best fit — highest urgency & budget in Kit Type.
Economic buyer76 fit
Urine Collection Kits
Strong fit — clear ROI and a fast path to value.
End user66 fit
Saliva Collection Kits
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Kit Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Sample Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Kit Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Specimen Collection Kit Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation12%
Closed-won6%
$10.4KCAC
$38KLTV
3.6:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Specimen Collection Kit Market is a durable-growth opportunity — $7.61B by 2033, compounding at 6.2%.
TAM · 2025$4.71Btoday
TAM · 2033$7.61Bforecast
CAGR6.2%2027–2033
Cumulative$54.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.61BTotal addressable market
SAM$2.87BServiceable available market
SOM$566MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.2% CAGR
Demand compounds through 2033, outpacing GDP across Kit Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Kit Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.61BLarge & growingTAM by 2033 at 6.2% CAGR
$2.87BServiceable nowreachable with today’s model
$566MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.93BBear4.0% CAGR
$7.61BBase6.2% CAGR
$9.74BBull8.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Specimen Collection Kit Market — a $7.65B market by 2033. Plan: grow share from 6.7% to 12.5%.
Market size · 2033$7.65Btotal addressable
Market CAGR5.2%2027–2033
Target share12.5%from 6.7% today
Revenue ambition$956Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.7% | 12.5% | Ahead |
| Revenue | $501M | $956M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.7% | 41.8% | Ahead |
| Customer retention | 87.9% | 92.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Kit Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Kit Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $96M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Kit Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Specimen Collection Kit Market conversation — a $5.52B market you can size, segment and defend in minutes.
Market size · 2033$5.52Btotal opportunity
Growth7.6%CAGR to 2033
Addressable buyers1,646+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Kit Type
Goal Grow share in Kit Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 3 mopayback period
$41K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificBecton Dickinson (BD)Greiner Bio-One International GmbHSarstedt AG & Co.Copan Diagnostics Inc.Fisher HealthcareNipro CorporationVWR International (part of Avantor)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Specimen Collection Kit Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Specimen Collection Kit Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Specimen Collection Device Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportSpecimen Collection Card Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportSpecific Protein Testing Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportSpecific Protein Analyzers Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportSpecific Protein Analysis System Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportSpecific Polypeptide Analyzers Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportSpecific Learning Disability Treatment Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportSpecific Antiviral Drugs for COVID-19 Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportSpecific Absorption Rate Testing System Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportSpecial Umbilical Cord Clamp Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportSpecialty Pharmacy Services Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportSpecialty Microscope Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.